Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2008;61:958-961; doi:10.1136/jcp.2008.058073
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

CASE REPORTS

Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3

A Tzankov1, K Sotlar2, D Muhlematter3, A Theocharides4, P Went1, M Jotterand3, H-P Horny5 and S Dirnhofer1

1 Institute of Pathology, University of Basel, Switzerland
2 Institute of Pathology, University of München, Germany
3 Institute of Medical Genetics, University of Lausanne, Switzerland
4 Department of Hematology, University of Basel, Switzerland
5 Institute of Pathology, Ansbach, Germany

Correspondence to:
Dr A Tzankov, University Hospital Basel, Institute of Pathology, Schoenbeinstr. 40, CH-4031 Basel, Switzerland; atzankov{at}uhbs.ch

Systemic mastocytoses represent neoplastic proliferations of mast cells. In about 20% of cases systemic mastocytoses are accompanied by clonal haematopoietic non-mast cell-lineage disorders, most commonly myeloid neoplasms. A case of systemic mastocytosis carrying the characteristic mutation at codon 816 (D816V) in the KIT gene of mast cells, with two concurrent accompanying clonal haematopoietic non-mast cell-lineage disorders, chronic myeloproliferative disease, unclassifiable and precursor B lymphoblastic leukaemia is documented. Both accompanying clonal haematopoietic non-mast cell-lineage disorders carried the wild-type KIT gene, but had a novel t(13;13)(q12;q22) involving the FLT3 locus at 13q12. The chronic myeloproliferative disease, unclassifiable and the precursor B lymphoblastic leukaemia were cured by syngenous stem cell transplantation, but the systemic mastocytosis persisted for more than 10 years. The additional impact of molecular techniques on the correct diagnosis in haematological malignancies is highlighted, and evidence is provided that, apart from internal tandem duplications and mutations, FLT3 can be activated by translocations.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs